Home › Funds › ARCH Venture Management, LLC › BEAM

ARCH Venture Management, LLC position in BEAM

BEAM THERAPEUTICS INC · Health Care

ARCH Venture Management, LLC reported holding 4,540,132 shares of BEAM (BEAM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$155.8M, representing 14.16% of its reported portfolio and ranking #2 among its reported holdings. ARCH Venture Management, LLC has disclosed BEAM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)4.54M sh
Reported value held$155.77M
Portfolio Weight14.16%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARCH Venture Management, LLC's BEAM position evolved

ARCH Venture Management, LLC first disclosed a stake in BEAM in Q2 2024 at 5,443,039 shares (US$127.5M). The position peaked in Q2 2026 at 4,540,132 shares, worth US$155.8M. Across 9 filings, ARCH Venture Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 4,540,132 shares valued at US$155.8M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 5.44M $127.53M New
Q3 2024 4.83M $118.45M Reduce
Q4 2024 4.54M $112.60M Reduce
Q1 2025 4.54M $88.67M Hold
Q2 2025 4.54M $77.23M Hold
Q3 2025 4.54M $110.19M Hold
Q4 2025 4.54M $125.85M Hold
Q1 2026 4.54M $108.19M Hold
Q2 2026 4.54M $155.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$351.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has ARCH Venture Management, LLC held BEAM?

ARCH Venture Management, LLC has disclosed BEAM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is ARCH Venture Management, LLC's current position in BEAM?

As of Q2 2026, ARCH Venture Management, LLC holds 4.54M shares of BEAM (BEAM THERAPEUTICS INC), valued at $155.77M, representing 14.16% of its reported portfolio and ranking #2.

Has ARCH Venture Management, LLC been buying or selling BEAM?

In the latest 13F filing (Q2 2026), ARCH Venture Management, LLC held unchanged its position in BEAM. The position peaked in Q2 2026 at 4.54M shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.